Sfoglia per RIVISTA
FUTURE ONCOLOGY (LONDON, ENGLAND)
Collezione AOU Alessandria
Items : 1
A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma. in Future oncology (London, England) / Future Oncol. 2021 Jan;17(3):255-262. doi: 10.2217/fon-2020-0794. Epub 2020 Sep 28.
2021
AOU Alessandria
Romano A; Novotny W; Co M; Huang H; Ladetto M; Smith SD; Wang M; Tam CS; Dreyling M; Holmgren E; Huang J; Gouill SL;